Founder and CEO
Founder and CEO
Julie works in business development for Rancho BioSciences liaising with customers and supporting projects. Julie brings years of executive international management experience in the life sciences business: GeneGo (systems biology), Thomson Reuters (scientific content), OminiViz (text mining), Genometrix (gene expression and genotyping), and Biosym/Accelrys (molecular modeling software). She has also advised and helped fund start-ups such as: FreedomVoice, aPriori Beauty Company, Simulscribe and Bimini Pet Health. Julie has also been involved in M&A activity selling GeneGo to Thomson Reuters and more recently supporting the GoDaddy acquisition of FreedomVoice.
Julie earned her science degree in England, has edited a Pathway book and is listed on several nutritional patents. Julie is also on the advisory board for Rady Children’s Hospital, Collaborations Pharmaceuticals and the Brain Trust Committee (John Wayne Cancer Institute).
PhD – Executive Director
Tatiana leads the international team of scientific data curators, bioinformaticians, and IT specialists. She has 12+ years of experience working with complex, patent-generating projects in science fields such as knowledge management, clinical curation and platform building (GeneGo/Thomson Reuters), as well as open source tools and platforms (tranSMART, Cytoscape, Connectivity map) as well as chemistry and therapeutic specific projects (BioFocus DPI).
Tatiana completed her Ph.D. in Physical Organic Chemistry (Univ. of Nevada, Reno) and post-doc training in peptidomimetics, Alzheimer’s and Huntington’s diseases (Univ. of California, Irvine)
Director of Business Development
Laura is working in the business development group supporting Rancho customers by providing novel solutions leveraging the extensive knowledge of the Rancho team. Laura has 12+ years of experience in international business development, with a solid understanding of the Systems Biology and Personalized Medicine market. She held management positions at GeneGo and Thomson Reuters, and worked with disease-specific non-profit foundations (Michael J Fox Foundation, Children’s Tumor Foundation), and start-ups (Bimini Pet Health, Pawtys).
Laura earned degrees in Computational Chemistry and Quantum Mechanics (UC San Diego) , published on the mechanism of action of a natural product cancer drug, and helped develop QM code for solvation cavities.
PhD – Head of Bioinformatics
John leads the bioinformatics scientific and technical program at Rancho and manages projects for the bioinformatics team. The team members study gene expressions changes, detect genetic variants, test statistical associations, analyze clinical trial data, and support the in-house bioinformatics team. John has 15+ years of biomedical research and software experience, in areas such as outbreaks of pandemic influenza strains, drug resistance in leukemia patients, genetic variants in cancer genomes, intrinsically unstructured proteins, and the prediction of protein-protein interactions. He previously led the BioInformatics Group core facility at St. Jude Children’s Research Hospital in Memphis, TN.
John has a Ph.D. in Biochemistry (Brandeis Univ.) and completed his post-doc fellowship in bioinformatics at MIT.
PhD – Curation Manager
Viktoria leads many projects at Rancho as an experienced curator and specializes in Omicsoft and NextBio pipelines as well as assay workflows. Viktoria has expertise in Developmental, Molecular, and Cellular Biology. She was a visiting scholar in the laboratories of Dr. Maciag, and later, Dr. Spicer at the Maine Medical Center Research Institute. Viktoria’s work includes cell cycle regulation after cell stimulation with peptide growth factors, Twist1 function during craniofacial development in mouse models, and Zebrafish mutations.
She earned her B.S. and M.S. in Chemistry (Moscow Institute of Fine Chemical Technology), and her Ph.D. in Molecular and Cellular Biology (Engelhardt Institute of Molecular Biology.
PhD – Senior Scientist
Oksana is leading projects in Rancho focused on knowledge mining, scientific data curation, target profiling and drug repositioning. Oksana has extensive knowledge in Developmental Biology and Molecular and Cellular Biology (Epigenetics, Cell Cycle and Apoptosis) and Regulation of Hormonal Signaling in Cancer Progression. She completed her post-doc fellowship at UC San Diego, and was a Research Scientist at M.G. Rosenfeld lab.
Oksana earned her B.S. and M.S. in Chemistry (Moscow State University), and her Ph.D. in Molecular and Cellular Biology (UMASS, Amherst).
Manager of Data Automation and Development Group
Leonya runs a group of innovative, experienced developers to produce de novo platforms and solutions for Rancho clients as well as leveraging open source platforms and tools. Leonya has diverse and extensive experience in software development, systems integration and large complex data streams structuring for a wide variety of clients (U.S. Library of Congress, U.S. Department of State, U.S. Small Business Administration, Toshiba Europe, British Royal Airforce, Mayo Clinic). He specializes in Java, Delphi, C, R, Python, Perl and Fortran, while mastering databases such as Oracle, MySQL, PostgreSQL and Access.
Leonya completed his M.A. in Linguistics and Computer Science (Moscow State Univ.)
PhD – Bioinformatics Scientist and
Manager of Translational Science and Bioinformatics.
Dan leads a dynamic team of bioinformatics and data scientists at Rancho whom tackle a wide range of biomedical analysis projects including: building custom analysis pipelines, glean mechanistic and strategic insight from clinical trial data, and facilitating big data processing in the cloud. His team functions by both integrating into existing in-house bioinformatics teams and working collaboratively to provide project-specific expertise. Dan brings with him a broad track record of academic and pharmaceutical industry success with over 12 years of biomedical research and project management experience in cancer biology, infectious disease and clinical data science.
Dan was awarded his PhD in Cell and Developmental Biology from the University of California, Davis for identifying a novel signalling network that recognizes aberrant chromosome divisions that could lead to the development of cancer. As a postdoctoral researcher in the National Emerging Infectious Diseases Lab (NEIDL) at Boston University, Dan made significant contributions towards the understanding of innate cellular defences against viral infection.